Related Experiment Video
Updated: May 20, 2026

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
Validation of a Paralimbic-Related Subcortical Brain Dysmaturation MRI Score in Infants with Congenital Heart Disease
William T Reynolds1, Jodie K Votava-Smith2,3, George Gabriel4
1Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15206, USA.
Insights
A new brain dysplasia score (BDS) detects subcortical abnormalities in infants with congenital heart disease (CHD), predicting developmental delays. The score was validated in a mouse model, suggesting common genetic causes for brain dysmaturation in CHD.
Area of Science:
- Neuroscience
- Developmental Biology
- Medical Imaging
Background:
- Infants with congenital heart disease (CHD) exhibit brain immaturity on MRI, previously assessed using cortical scores.
- Paralimbic-related subcortical brain structures are crucial for development and function, yet their assessment in CHD infants is limited.
Purpose of the Study:
- To develop and validate a semi-quantitative brain dysplasia score (BDS) for detecting subcortical abnormalities in infants with CHD.
- To assess the BDS's ability to predict clinical outcomes and neurodevelopmental trajectories in CHD infants.
- To validate the BDS in a preclinical mouse model of hypoplastic left heart syndrome.
Main Methods:
- Structural MRIs from CHD infants (n=215) and healthy controls (n=92) were analyzed to derive the paralimbic-related subcortical BDS.
- BDS was correlated with clinical factors, regional brain volumes, feeding status, and 18-month neurodevelopmental outcomes.
- The BDS was validated in a CHD mouse model (Ohia) with identified genetic mutations (Sap130, Pchda9), using RNA-Seq for pathway analysis.
Main Results:
- The BDS identified a high incidence of subcortical abnormalities (olfactory, cerebellar, hippocampal) in CHD infants compared to controls.
- BDS correlated significantly with reduced cortical maturation, developmental delays, impaired language and feeding, and longer hospital stays.
- The Ohia mouse model showed similar BDS findings, with RNA-Seq revealing altered neurodevelopmental and feeding pathways; Sap130 mutants had a more severe BDS.
Conclusions:
- The developed BDS is a sensitive tool for identifying brain dysmaturation in CHD infants and predicting adverse clinical outcomes.
- The findings in the Ohia mouse model suggest shared genetic mechanisms underlying paralimbic and subcortical abnormalities in human CHD.
- The BDS offers a novel approach to characterizing brain abnormalities in CHD, potentially guiding early interventions and research into genetic etiologies.
Abstract:
Background: Brain magnetic resonance imaging (MRI) of infants with congenital heart disease (CHD) shows brain immaturity assessed via a cortical-based semi-quantitative score. Our primary aim was to develop an infant paralimbic-related subcortical-based semi-quantitative dysmaturation score, termed brain dysplasia score (BDS), to detect abnormalities in CHD infants compared to healthy controls and secondarily to predict clinical outcomes. We also validated our BDS in a preclinical mouse model of hypoplastic left heart syndrome. Methods: A paralimbic-related subcortical BDS, derived from structural MRIs of infants with CHD, was compared to healthy controls and correlated with clinical risk factors, regional cerebral volumes, feeding, and 18-month neurodevelopmental outcomes. The BDS was validated in a known CHD mouse model named Ohia with two disease-causing genes, Sap130 and Pchda9. To relate clinical findings, RNA-Seq was completed on Ohia animals. Findings: BDS showed high incidence of paralimbic-related subcortical abnormalities (including olfactory, cerebellar, and hippocampal abnormalities) in CHD infants (n = 215) compared to healthy controls (n = 92). BDS correlated with reduced cortical maturation, developmental delay, poor language and feeding outcomes, and increased length of stay. Ohia animals (n = 63) showed similar BDS findings, and RNA-Seq analysis showed altered neurodevelopmental and feeding pathways. Sap130 mutants correlated with a more severe BDS, whereas Pcdha9 correlated with a milder phenotype. Conclusions: Our BDS is sensitive to dysmaturational differences between CHD and healthy controls and predictive of poor outcomes. A similar spectrum of paralimbic and subcortical abnormalities exists between human and Ohia mutants, suggesting a common genetic mechanistic etiology.
More Related Videos
11:50A Standardized Pipeline for Examining Human Cerebellar Grey Matter Morphometry using Structural Magnetic Resonance Imaging
Published on: February 4, 2022
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies for Cardiovascular System IV: CMRI